Chemed Corp: updates and filings

CHENYSEHealthcare · Services-Home Health Care Services

Price

$550.12

November 17, 2026Market cap $7.2B

What Ploutos Investor adds for Chemed

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 71 daysAround Jan 27, 2027 · for Q4 2026

last Oct 27, 2026next Jan 27, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 27, 2026 latest annualOct 29, 2026 latest quarterly
  • Oct 29, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 27, 2026Results of operations
    Form8-K
  • Aug 12, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Jul 31, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jul 28, 2026Results of operations
    Form8-K
  • Jun 24, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • May 19, 2026Shareholder vote
    Form8-K
  • Apr 29, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 29, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 28, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • Apr 23, 2026Results of operations
    Form8-K
  • Apr 13, 2026Material agreement entered, new material financial obligation
    Form8-K
  • Apr 9, 2026Filing
    FormDEFR14A
  • Apr 6, 2026Annual meeting proxy statement
    FormDEF 14A
  • Mar 26, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Feb 27, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Feb 25, 2026Results of operations
    Form8-K
  • Oct 31, 2025Quarterly reportfor the period to Sep 30, 2025
    Form10-Q
  • Oct 28, 2025Results of operations
    Form8-K
  • Jul 31, 2025Quarterly reportfor the period to Jun 30, 2025
    Form10-Q
  • Jul 29, 2025Results of operations, officer or director change
    Form8-K
  • Jun 27, 2025Regulation FD disclosure
    Form8-K
  • Jun 27, 2025Employee stock plan reportfor the period to Dec 31, 2024
    Form11-K
  • May 22, 2025Filing
    FormS-8 POS
  • May 20, 2025Shareholder vote
    Form8-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 14, 1994.

The full analysis

What do Chemed's filings show?

The filings are where every one of Chemed's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.